Haikou, China · Founded 2020 · In IPO Registration
Developer and manufacturer of innovative oncology drugs designed for treating cancer patients with unmet clinical needs. Simcere Zaiming is based in Haikou, China and was founded in 2020. Its last reported valuation was $1.2 billion in Jun 2025. It has raised $148 million.
Last reported valuation
$1.2B
Oct 2026
Priced at
—
Total raised
$148.4M
Last round
—
Cap table — not yet on record
Simcere Zaiming's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Simcere Zaiming with a free account
·Watch Simcere Zaiming: the Monday email on marks, rounds and moves
